This mechanism has been previously reported in HNSCC [12, 13], and upregulation of BCL-2 has been shown to be associated with cisplatin resistance and poor outcome in oropharyngeal squamous cell carcinoma [14, 15]. Here, BCL2 is linked to head and neck squamous cell carcinoma.